Kelly A. Conrads, PhD
Senior Research Scientist
Gynecologic Cancer Center of Excellence
3289 Woodburn Rd
Suite 375
Annandale,
VA
USA
22003
Papers:
43 - Featured Poster
Identification of candidate circulating cisplatin resistance biomarkers from epithelial ovarian carcinoma cell secretomes
49 - Featured Poster
Pathogenesis of ARID1A-driven gynecologic cancer
52 - Featured Poster
Pharmacologic inhibition of the DNA damage response kinases ATR (ataxia telangiectasia and rad3 related) and ATM (ataxia telangiectasia mutated) broadly sensitizes diverse subtypes of gynecologic cancer cells to ionizing radiation
269 - Poster Session A
Enhanced gynecologic cancer cell killing through pharmacologic inhibition of the ataxia telangiectasia and Rad3-related kinase
306 - Poster Session A
Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells